Enveric Biosciences, Inc. (ENVB)
Largest Insider Buys in Sector
ENVB Stock Price History Chart
ENVB Stock Performance
About Enveric Biosciences, Inc.
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Insider Activity of Enveric Biosciences, Inc.
Over the last 12 months, insiders at Enveric Biosciences, Inc. have bought $0 and sold $0 worth of Enveric Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Enveric Biosciences, Inc. have bought $2,140 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,000 shares for transaction amount of $2,140 was made by PASQUALONE FRANK (director) on 2023‑09‑15.
List of Insider Buy and Sell Transactions, Enveric Biosciences, Inc.
| 2023-09-15 | director | 1,000 0.043% | $2.14 | $2,140 | -58.29% | |||
| 2018-11-16 | Sale | 10 percent owner | 100,000 1.778% | $0.30 | $29,550 | -7.33% | ||
| 2018-11-16 | Sale | 10 percent owner | 100,000 1.778% | $0.30 | $29,550 | -7.33% | ||
| 2018-11-16 | Sale | 10 percent owner | 100,000 1.778% | $0.30 | $29,550 | -7.33% | ||
| 2018-11-16 | Sale | 10 percent owner | 100,000 1.778% | $0.30 | $29,550 | -7.33% | ||
| 2018-07-17 | Sale | 10 percent owner | 100,000 2.4059% | $2.27 | $226,630 | -80.34% | ||
| 2018-06-07 | Sale | 10 percent owner | 329,357 10.2759% | $2.01 | $661,316 | -74.45% | ||
| 2017-11-17 | 100,000 2.8873% | $4.12 | $411,500 | -58.17% | ||||
| 2017-11-17 | President & CEO | 12,121 0.35% | $4.12 | $49,878 | -58.17% | |||
| 2017-11-17 | director | 145,450 4.1995% | $4.12 | $598,527 | -58.17% | |||
| 2017-10-30 | 1,303 0.0319% | $6.50 | $8,469 | -76.92% | ||||
| 2017-10-27 | 2,500 0.0612% | $6.50 | $16,250 | -76.92% | ||||
| 2017-09-06 | 7,500 0.2039% | $6.50 | $48,750 | -75.23% | ||||
| 2017-08-21 | 2,604 0.0672% | $6.50 | $16,924 | -76.35% | ||||
| 2017-03-30 | 223 0.0063% | $6.51 | $1,452 | -60.83% | ||||
| 2017-02-10 | 434 0.0123% | $6.51 | $2,825 | -53.23% | ||||
| 2017-01-23 | 2,130 0.0605% | $6.51 | $13,866 | -50.54% | ||||
| 2017-01-18 | 10,000 0.2839% | $6.51 | $65,100 | -50.84% | ||||
| 2016-12-30 | 40 0.0012% | $6.51 | $260 | -52.38% | ||||
| 2016-12-29 | 706 0.0203% | $6.51 | $4,596 | -52.38% |
Institutional Investor Ownership
| AdvisorShares | $238,833.00 | 3.08 | 238,833 | +68.39% | +$97,000.00 | 0.02 | |
| Hrt Financial Llc | $63,000.00 | 0.81 | 63,026 | New | +$63,000.00 | <0.0001 | |
| Citadel Advisors LLC | $40,104.00 | 0.52 | 40,104 | New | +$40,104.00 | <0.0001 | |
| Virtu Financial Llc | $34,000.00 | 0.44 | 33,835 | New | +$34,000.00 | <0.01 | |
| BlackRock | $29,578.00 | 0.38 | 29,578 | 0% | +$0 | <0.0001 |